What does GM1 antibody test for?
Measurement of IgM antibodies to GM1 (Anti-GM1) has been employed in the evaluation of with chronic neuropathies that affect the motor nerves. IgM Anti-GM1 seropositivity is significantly associated with multifocal motor neuropathy (MMN).
What is anti-GM1 antibody?
Ganglioside antibodies are associated with diverse peripheral neuropathies. Elevated antibody levels to ganglioside-monosialic acid (GM1) are associated with motor or sensorimotor neuropathies, particularly multifocal motor neuropathy. Anti-GM1 may occur as IgM (polyclonal or monoclonal) or IgG antibodies.
What is asialo GM1?
Ganglio-N-tetraosylceramide (asialo GM1), an antigen common to the brain and immune system: its localization in myelin. Brain Res.
What is motor neuropathy?
Multifocal motor neuropathy (MMN) is a disease that affects your body’s motor nerves. Those are the nerves that control your muscles. The condition makes it hard for them to send the electrical signals that move your body, which makes your hands and arms feel weak. They’ll also twitch and cramp.
What is acute motor axonal neuropathy?
Acute motor axonal neuropathy (AMAN) is a variant type of Guillain-Barre Syndrome (GBS). AMAN is a non-inflammatory disease whereby axons of motor nerve cells are selectively targeted and destroyed by the body’s own immune system. The myelin sheath surrounding the axon is unaffected.
Can MMN turn into ALS?
In a US study of 46 patients with MMN referred to a tertiary neuromuscular center, only 6 were previously given the correct diagnosis. 2 The ratio of MMN to ALS is approximately 1 to 20, and patients with MMN are often diagnosed as having ALS.
Can ALS be misdiagnosed as MMN?
Confusion of MMN with ALS is not uncommon in clinical practice and misdiagnosis is common [13]. MMN is a rare immune-mediated neuropathy that is treatable with immunomodulatory therapy early in the course of the disease before the occurrence of axonal degeneration.
What does it mean when your GM1 antibody is elevated?
Elevated antibody levels to ganglioside-monosialic acid (GM1) are associated with motor or sensorimotor neuropathies, particularly multifocal motor neuropathy. Anti-GM1 may occur as IgM (polyclonal or monoclonal) or IgG antibodies.
What is the pathophysiology of anti-GM1 antibodies in neuropathy?
Elevated antibody levels to ganglioside-monosialic acid (GM1) are associated with motor or sensorimotor neuropathies, particularly multifocal motor neuropathy. Anti-GM1 may occur as IgM (polyclonal or monoclonal) or IgG antibodies. These antibodies may also be found in patients with diverse connective tissue diseases as well as normal individuals.
Are high-titer IgM antibodies effective against monosialo GM1 in patients with neuropathy?
High-titer IgM antibodies against monosialo GM1 occurred only in patients with various forms of pure motor neuropathy (100% specificity). The sensitivity was 50% for this referral-based population. Publication types
What is ganglioside monosialic acid (GM1) antibody?
Ganglioside antibodies are associated with diverse peripheral neuropathies. Elevated antibody levels to ganglioside-monosialic acid (GM1) are associated with motor or sensorimotor neuropathies, particularly multifocal motor neuropathy. Anti-GM1 may occur as IgM (polyclonal or monoclonal) or IgG antibodies.
